Patent · US Active

Disintegrable formulations of lanthanum carbonate

US8962036B2 · kind B2 · utility

0Cited by

3References

23Claims

0Family size

Assignee

Mylan Pharmaceuticals Inc. · US

Inventors

Andrea Works · Morgantown, US
John Twist · Morgantown, US
Okey Noe · Morgantown, US

Key dates

Filing date	Jan 21, 2010
Grant date	Feb 24, 2015
Priority date	—
Expiry date	May 16, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/19
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disintegrable preparations of lanthanum carbonate prepared by co-precipitation, facilitating the manufacture of oral pharmaceutical dosage forms such as tablets, capsules, powders, granules, and sprinkles, and the use of such dosage forms to treat subjects with hyperphosphatemia are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.